Initial rituximab monotherapy for adult indiopathic nephrotic syndrome with minimal change lesion pattern
Nephrology Dialysis Transplantation · 2024
DOI: 10.1093/ndt/gfae012 ↗Kurz gefasst
Leserbrief in der Zeitschrift Nephrology Dialysis Transplantation, 2024. Verfasst von Ricong Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Nephrosis, Lipoid, Nephrotic Syndrome, Rituximab. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Basic Research Program of the Shenzhen Science and Technology R & D Fund, Shenzhen Second People's Hospital Clinical Research Fund of Guangdong Province High-level Hospital Construction Project.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China.
- Department of Nephrology, Longgang Orthopedics Hospital of Shenzhen, Shenzhen, Guangdong, China.
- Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
ORCID-Profile: Qijun Wan
Förderung
- National Natural Science Foundation of China
- Basic Research Program of the Shenzhen Science and Technology R & D Fund
- Shenzhen Second People's Hospital Clinical Research Fund of Guangdong Province High-level Hospital Construction Project
- Shenzhen Key Medical Discipline Construction Fund
Zitieren
APA
Xu, R., Hu, H., Xu, H., Li, Z., Guo, J., Cao, T., Yu, Y., Chen, X., Xu, Y., & Wan, Q. (2024). Initial rituximab monotherapy for adult indiopathic nephrotic syndrome with minimal change lesion pattern. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfae012
Vancouver
Xu R, Hu H, Xu H, Li Z, Guo J, Cao T, et al. Initial rituximab monotherapy for adult indiopathic nephrotic syndrome with minimal change lesion pattern. Nephrology Dialysis Transplantation. 2024. doi:10.1093/ndt/gfae012
BibTeX
@article{Xu2024,
author = {Xu, Ricong and Hu, Haofei and Xu, Hengchang and Li, Zhijian and Guo, Jianying and Cao, Tao and Yu, Yi and Chen, Xiaojie and Xu, Yi and Wan, Qijun},
title = {Initial rituximab monotherapy for adult indiopathic nephrotic syndrome with minimal change lesion pattern},
journal = {Nephrology Dialysis Transplantation},
year = {2024},
doi = {10.1093/ndt/gfae012}
}
EUVIMED